ACHN - Achillion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5528.04M
Enterprise Value 3300.23M
Trailing P/E N/A
Forward P/E 1-4.91
PEG Ratio (5 yr expected) 1-0.35
Price/Sales (ttm)N/A
Price/Book (mrq)2.27
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-3.99

Trading Information

Stock Price History

Beta (3Y Monthly) 1.62
52-Week Change 38.55%
S&P500 52-Week Change 32.63%
52 Week High 35.0300
52 Week Low 31.2900
50-Day Moving Average 34.3806
200-Day Moving Average 33.3236

Share Statistics

Avg Vol (3 month) 31.53M
Avg Vol (10 day) 3940.4k
Shares Outstanding 5139.69M
Float 125.56M
% Held by Insiders 10.15%
% Held by Institutions 178.62%
Shares Short (Aug 15, 2019) 48.35M
Short Ratio (Aug 15, 2019) 43.22
Short % of Float (Aug 15, 2019) 46.18%
Short % of Shares Outstanding (Aug 15, 2019) 45.98%
Shares Short (prior month Jul 15, 2019) 48.31M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-17.34%
Return on Equity (ttm)-26.94%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-50.12M
EBITDA -75.3M
Net Income Avi to Common (ttm)-70.87M
Diluted EPS (ttm)-0.5110
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)233.37M
Total Cash Per Share (mrq)1.67
Total Debt (mrq)1.37M
Total Debt/Equity (mrq)0.59
Current Ratio (mrq)14.64
Book Value Per Share (mrq)1.67

Cash Flow Statement

Operating Cash Flow (ttm)-56.51M
Levered Free Cash Flow (ttm)-31.65M